Estrogen and Abdominal Muscle Fibrosis
雌激素与腹肌纤维化
基本信息
- 批准号:9916751
- 负责人:
- 金额:$ 60.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-16 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:Abdominal MusclesAdjuvantAffectAgingAppearanceAreaAromataseAromatase InhibitorsAtrophicBioinformaticsBiologicalBiopsyBrainChIP-seqCombined Modality TherapyDataDevelopmentDiseaseElderly manEstradiolEstradiol AntagonistsEstrogen Receptor alphaEstrogen ReceptorsEstrogensEtiologyExtracellular MatrixFatty acid glycerol estersFibroblastsFibrosisFulvestrantGenesGeneticGenomicsHerniaHernia of abdominal cavityHumanImmunoblottingImmunohistochemistryIncidenceInfectionInguinal HerniaInterventionLabelLeadLengthLetrozoleMapsMediatingMessenger RNAModelingMolecularMusMuscleMuscle CellsMuscle FibersMuscle WeaknessMuscular AtrophyNucleic Acid Regulatory SequencesOperative Surgical ProceduresPainPathway AnalysisPathway interactionsPatientsPatternPeripheralPharmacologic SubstancePhenotypePhysiologicalPhysiologyPopulationPostoperative PainPrevalencePreventiveProductionProteinsPyrazolesRNA analysisRecurrenceRefractoryRoleS100A4 geneSignal TransductionSkeletal MuscleSteroidsSurgeonTestisTestosteroneTimeTissuesTransgenic OrganismsUnited States National Institutes of HealthWild Type Mouseabdominal wallclinically relevantconditional knockoutestrogen disruptionestrogenicexperimental studygenetic signaturegenome-widehigh risk populationhistone modificationhuman diseasemalemenmorphometrymortalitymouse modelnew therapeutic targetnovelpostnatalpreventquadriceps musclereceptor expressionrepairedskeletal muscle wastingtranscriptometranscriptome sequencing
项目摘要
Although more than 1 in 4 men can be expected to develop symptomatic inguinal hernia, its mechanism is
currently unknown. A subset of hernias may develop due to muscle fibrosis and myofiber atrophy leading to
lower abdominal wall weakness. The long-term objective of this application is to determine the role of estrogen
action in the etiology of lower abdominal muscle tissue (LAMT) fibrosis and atrophy associated with a subset of
inguinal hernias. Aromatase, which converts testosterone to estradiol, is expressed only in the brain and testes
of male mice. However, in men, aromatase is expressed in many additional tissues (muscle, fat) to provide
physiologically necessary local quantities of estrogen. We generated transgenic humanized aromatase
(Aromhum) mouse lines, each containing a single copy of the full-length human aromatase gene including its
regulatory region, to mimic human patterns of estrogen production. Aromhum mice express the aromatase gene
in peripheral tissues including the fibroblast component of the skeletal muscle tissue. LAMT has been found to
be more sensitive to estradiol than the upper abdominal or quadriceps muscles, because the stroma of LAMT
contains strikingly larger amounts of estrogen receptor- (ER)-expressing fibroblasts. Locally increased
concentrations of estradiol in LAMT was associated with LAMT fibrosis characterized by progressive
replacement of atrophic myocytes (muscle fibers) with ER-rich fibroblasts and excessive extracellular matrix,
resulting in formation of large inguinal hernias in >90% of Aromhum male mice by 24 weeks. However, there
were no hernias observed in any of the wild-type (WT) littermates. Microarray expression analysis of LAMT at
four weeks (before the appearance of hernias) showed activated profibrotic pathways in Aromhum vs. WT mice.
We hypothesize that enhanced estrogen action caused by locally formed estradiol drives muscle fibrosis and
myocyte atrophy, leading to the hernia phenotype affecting highly estrogen-sensitive portions of skeletal
muscle tissue, which is LAMT in Aromhum mice. This resonates with the remarkable and parallel increases in
inguinal hernia incidence and increased aromatase expression in skeletal muscle and fat in aging men. To
ascertain the underlying mechanisms, we propose the following aims: 1. Determine whether treatment with an
aromatase inhibitor, an estradiol antagonist, or a highly selective ERα antagonist prevents fibrosis, LAMT
muscle atrophy, and hernia formation in Aromhum mice. The estradiol/ER-mediated genomic mechanisms
responsible for disordered proliferation of fibroblasts and extracellular matrix formation will be determined using
integrative analysis of RNA-seq and ER-ChIP-seq on LAMT and fibroblasts. 2. Determine whether the
genetic disruption of ER selectively in skeletal muscle fibroblasts affects LAMT fibrosis and hernia formation
in Aromhum mice. In parallel, we will assess tissue steroid levels, aromatase and ERexpression, and estrogen
responsive genes in abdominal muscle biopsies of men with or without hernia. We anticipate that this novel
proposal will identify new drug targets and likely lead to the discovery of preventive approaches for hernia in
high-risk populations.
尽管预计每4名男性中就有1人会出现症状性腹股沟疝气,但其机制是
目前尚不清楚。由于肌肉纤维化和肌纤维萎缩导致的一组腹股沟疝气
下腹壁无力。这种应用的长期目标是确定雌激素的作用。
在下腹部肌肉组织(LAMT)纤维化和萎缩的病因学中的作用
腹股沟疝气。将睾丸激素转化为雌二醇的芳香化酶只在大脑和睾丸中表达。
雄鼠的数量。然而,在男性中,芳香化酶在许多额外的组织(肌肉、脂肪)中表达,以提供
生理上必需的局部剂量的雌激素。我们产生了转基因人源化芳香酶
(Aromhum)小鼠品系,每个品系都包含一个全长人类芳香酶基因的单一副本,包括其
调节区域,以模仿人类产生雌激素的模式。芳香族小鼠表达芳香酶基因
在外周组织中,包括骨骼肌组织的成纤维细胞成分。LAMT已被发现
对雌二醇比上腹部或股四头肌更敏感,因为LAMT的间质
含有大量表达雌激素受体-(ER-)的成纤维细胞。本地增长
LAMT中雌二醇浓度与以进行性LAMT纤维化为特征的LAMT相关
用富含ER的成纤维细胞和过量的细胞外基质取代萎缩的肌细胞(肌肉纤维),
结果在24周时,90%的阿罗姆雄性小鼠形成了巨大的腹股沟腹股沟疝气。然而,在那里
在任何野生型(WT)产仔中均未观察到腹股沟。LAMT基因的微阵列表达分析
四周(在出现疝气之前),在Aromhum和WT小鼠中显示了激活的促纤维化通路。
我们假设,局部形成的雌二醇引起的雌激素作用增强会推动肌肉纤维化和
肌细胞萎缩,导致影响骨骼高度雌激素敏感部分的疝表型
肌肉组织,这是阿罗姆小鼠的LAMT。这与显著的平行增长产生了共鸣
老年男性腹股沟疝气发生率和骨骼肌和脂肪中芳香化酶表达增加。至
为了弄清潜在的机制,我们提出了以下目标:1.确定是否用一种
芳香酶抑制剂、雌二醇拮抗剂或高选择性ERα拮抗剂预防纤维化
阿罗姆小鼠肌肉萎缩和腹股沟形成。雌激素/雌激素受体介导的基因组机制
对成纤维细胞无序增殖和细胞外基质形成的责任将通过
Rna-seq和ER--chIP-seq对LAMT和成纤维细胞的整合分析。2.确定是否
选择性破坏骨骼肌成纤维细胞ER基因影响肌筋膜成纤维细胞纤维化和疝气形成
在阿罗姆小鼠身上。同时,我们将评估组织类固醇水平、芳香酶和ER的表达,以及雌激素
有无疝气男性腹肌活检中的反应基因。我们预计这部小说
该提案将确定新的药物靶点,并可能导致发现预防腹股沟疝气的方法
高危人群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Serdar E. Bulun其他文献
グラビア・目で見る遺伝子異常と婦人科内分泌疾患―早発卵巣不全―
凹印/可见基因异常与妇科内分泌疾病 - 卵巢早衰 -
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Masanori Ono;Tetsuo Maruyama;Mamoru Tanaka;Daisuke Aoki;Serdar E. Bulun;河村和弘・佐藤可野・鈴木直 - 通讯作者:
河村和弘・佐藤可野・鈴木直
STEROYL-CoA DESATURASE INHIBITION IS ASSOCIATED WITH DECREASED UTERINE LEIOMYOMA CELL VIABILITY
- DOI:
10.1016/j.fertnstert.2023.08.600 - 发表时间:
2023-10-01 - 期刊:
- 影响因子:
- 作者:
Allison S. Komorowski;Azna Zuberi;John S. Coon V;Melania Anton;Serdar E. Bulun;Ping Yin - 通讯作者:
Ping Yin
Therapeutic targeting of the tryptophan-kynurenine-aryl hydrocarbon receptor pathway with apigenin in MED12-mutant leiomyoma cells
芹菜素对 MED12 突变型平滑肌瘤细胞中色氨酸-犬尿氨酸-芳烃受体通路的治疗靶向作用
- DOI:
10.1038/s41417-025-00881-0 - 发表时间:
2025-03-01 - 期刊:
- 影响因子:5.000
- 作者:
Takashi Iizuka;Azna Zuberi;Helen Wei;John S. Coon V;Melania Lidia Anton;Kadir Buyukcelebi;Mazhar Adli;Serdar E. Bulun;Ping Yin - 通讯作者:
Ping Yin
Role of WNT/CTNNB1 pathway in differentiation of human induced pluced pluripotent stem cells to endometrial stroma-like cells
WNT/CTNNB1通路在人诱导多能干细胞向子宫内膜基质样细胞分化中的作用
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Kaoru Miyazaki;Matthew T. Dyson;John S. Coon;Tetsuo Maruyama;Serdar E. Bulun - 通讯作者:
Serdar E. Bulun
Transcriptome analysis of endometrial stroma-like ofganoids differentiated from human induced pluripotent stem cells
人诱导多能干细胞分化的子宫内膜基质样细胞的转录组分析
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Kaoru Miyazaki ;Matthew T. Dyson ;John S. Coon;Maruyama T;Serdar E. Bulun - 通讯作者:
Serdar E. Bulun
Serdar E. Bulun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Serdar E. Bulun', 18)}}的其他基金
Estrogen, Astrocyte Reactivity, and Sex Differences in Alzheimer's Disease
阿尔茨海默病中的雌激素、星形胶质细胞反应性和性别差异
- 批准号:
10662993 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:
Environmental Pollutants and AHR pathway in Uterine Leiomyoma
环境污染物与子宫平滑肌瘤的 AHR 通路
- 批准号:
10567192 - 财政年份:2022
- 资助金额:
$ 60.03万 - 项目类别:
Epigenome, MED12 and Progesterone Action in Uterine Leiomyomas
表观基因组、MED12 和孕酮在子宫平滑肌瘤中的作用
- 批准号:
10396486 - 财政年份:2019
- 资助金额:
$ 60.03万 - 项目类别:
Epigenome, MED12 and Progesterone Action in Uterine Leiomyomas
表观基因组、MED12 和孕酮在子宫平滑肌瘤中的作用
- 批准号:
10153842 - 财政年份:2019
- 资助金额:
$ 60.03万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:
Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 60.03万 - 项目类别:














{{item.name}}会员




